Poster presenters at our annual conferences often continue their research or program long after the event. Read on for more from Deirdre Lombardi, MPH, CPH, CHES, Challace Pahlevan-Ibrekic, CIP, MS, Brenda Ruotolo, BA, CIP, and Alan Teller, CIP, who presented a poster titled Development of a Specialized IRB for Genetics and Genomics Research, at the 2016 Advancing Ethical Research Conference (AER16). Read more
TAG ARCHIVES FOR genetics and genomics
This week’s Research Ethics Roundup highlights how the "moonshot" initiative could lead to changes in clinical trial participation and how studying dogs’ DNA profiles may lead to advances in psychiatric research for humans. Read more
From the progress in gene therapy for genetic retinal diseases to a survey that finds the majority of animal studies for drugs are not rigorous enough, this week’s Research Ethics Roundup examines some of the latest controversial issues occurring in research ethics.
From Eli Lilly abandoning evacetrapib in the final stages of trials to the surprising placebo effect, this week’s Research Ethics Roundup shines the spotlight on clinical trials that could shape the future of research.
Gene Editing Record Smashed in Pigs: A team from Harvard Medical School, led by geneticist George Church, has used CRISPR technology to modify more than 20 genes in pig embryo and deactivate more than 60 viruses that could cause disease in human [...] Read more
Two recent studies have generated debate within the research community. We explore those studies, as well as other recent stories about research in the popular media, in this week’s Research Ethics Roundup.
Has US Biomedical Research on Chimpanzees Come to an End?: In June, the US Fish and Wildlife Service announced its plans to classify captive chimpanzees, including those used for research purposes, as endangered animals under the Endangered Species Act. In this article for Science, David Grimm explores the effect of that decision.